New Insights into Therapeutic Targets in Myeloma

被引:39
作者
Anderson, Kenneth C. [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02215 USA
来源
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM | 2011年
关键词
D O I
10.1182/asheducation-2011.1.184
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Patient outcome in multiple myeloma (MM) has been remarkably improved due to the use of combination therapies including proteasome inhibitors and immunomodulatory drugs, which target the tumor in its BM microenvironment. Ongoing efforts to improve the treatment paradigm even further include using oncogenomics to better characterize molecular pathogenesis and to develop refined patient stratification and personalized medicine in MM; using models of MM in its BM milieu to identify novel targets and to validate next-generation therapeutics directed at these targets; developing immune-based therapies including mAbs, immunotoxins targeting MM cells and cytokines, and novel vaccine strategies; and using functional oncogenomics to inform the design of novel combination therapies. With continued rapid evolution of progress in these areas, MM will be a chronic illness with sustained complete response in a significant number of patients.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 68 条
[1]   Prognostic Significance of Copy-Number Alterations in Multiple Myeloma [J].
Avet-Loiseau, Herve ;
Li, Cheng ;
Magrangeas, Florence ;
Gouraud, Wilfried ;
Charbonnel, Catherine ;
Harousseau, Jean-Luc ;
Attal, Michel ;
Marit, Gerald ;
Mathiot, Claire ;
Facon, Thierry ;
Moreau, Philippe ;
Anderson, Kenneth C. ;
Campion, Loic ;
Munshi, Nikhil C. ;
Minvielle, Stephane .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4585-4590
[2]  
Bae J, LEUKEMIA IN PRESS
[3]   The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition [J].
Bianchi, Giada ;
Oliva, Laura ;
Cascio, Paolo ;
Pengo, Niccolo ;
Fontana, Francesca ;
Cerruti, Fulvia ;
Orsi, Andrea ;
Pasqualetto, Elena ;
Mezghrani, Alexandre ;
Calbi, Valeria ;
Palladini, Giovanni ;
Giuliani, Nicola ;
Anderson, Kenneth C. ;
Sitia, Roberto ;
Cenci, Simone .
BLOOD, 2009, 113 (13) :3040-3049
[4]   Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma [J].
Breitkreutz, I. ;
Raab, M. S. ;
Vallet, S. ;
Hideshima, T. ;
Raje, N. ;
Mitsiades, C. ;
Chauhan, D. ;
Okawa, Y. ;
Munshi, N. C. ;
Richardson, P. G. ;
Anderson, K. C. .
LEUKEMIA, 2008, 22 (10) :1925-1932
[5]   Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial [J].
Broyl, Annemiek ;
Corthals, Sophie L. ;
Jongen, Joost L. M. ;
van der Holt, Bronno ;
Kuiper, Rowan ;
de Knegt, Yvonne ;
van Duin, Mark ;
el Jarari, Laila ;
Bertsch, Uta ;
Lokhorst, Henk M. ;
Durie, Brian G. ;
Goldschmidt, Hartmut ;
Sonneveld, Pieter .
LANCET ONCOLOGY, 2010, 11 (11) :1057-1065
[6]   Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients [J].
Broyl, Annemiek ;
Hose, Dirk ;
Lokhorst, Henk ;
de Knegt, Yvonne ;
Peeters, Justine ;
Jauch, Anna ;
Bertsch, Uta ;
Buijs, Arjan ;
Stevens-Kroef, Marian ;
Beverloo, H. Berna ;
Vellenga, Edo ;
Zweegman, Sonja ;
Kersten, Marie-Josee ;
van der Holt, Bronno ;
el Jarari, Laila ;
Mulligan, George ;
Goldschmidt, Hartmut ;
van Duin, Mark ;
Sonneveld, Pieter .
BLOOD, 2010, 116 (14) :2543-2553
[7]   High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients [J].
Carrasco, DR ;
Tonon, G ;
Huang, YS ;
Zhang, YY ;
Sinha, R ;
Bin, F ;
Stewart, JP ;
Zhan, FG ;
Khatry, D ;
Protopopova, M ;
Protopopov, A ;
Sukhdeo, K ;
Hanamura, I ;
Stephens, O ;
Barlogie, B ;
Anderson, KC ;
Chin, L ;
Shaughnessy, JD ;
Brennan, C ;
DePinho, RA .
CANCER CELL, 2006, 9 (04) :313-325
[8]   Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells [J].
Catley, Laurence ;
Weisberg, Ellen ;
Kiziltepe, Tanyel ;
Tai, Yu-Tzu ;
Hideshima, Teru ;
Neri, Paola ;
Tassone, Pierfrancesco ;
Atadja, Peter ;
Chauhan, Dharminder ;
Munshi, Nikhil C. ;
Anderson, Kenneth C. .
BLOOD, 2006, 108 (10) :3441-3449
[9]   Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study [J].
Cavo, Michele ;
Tacchetti, Paola ;
Patriarca, Francesca ;
Petrucci, Maria Teresa ;
Pantani, Lucia ;
Galli, Monica ;
Di Raimondo, Francesco ;
Crippa, Claudia ;
Zamagni, Elena ;
Palumbo, Antonio ;
Offidani, Massimo ;
Corradini, Paolo ;
Narni, Franco ;
Spadano, Antonio ;
Pescosta, Norbert ;
Deliliers, Giorgio Lambertenghi ;
Ledda, Antonio ;
Cellini, Claudia ;
Caravita, Tommaso ;
Tosi, Patrizia ;
Baccarani, Michele .
LANCET, 2010, 376 (9758) :2075-2085
[10]   Initial genome sequencing and analysis of multiple myeloma [J].
Chapman, Michael A. ;
Lawrence, Michael S. ;
Keats, Jonathan J. ;
Cibulskis, Kristian ;
Sougnez, Carrie ;
Schinzel, Anna C. ;
Harview, Christina L. ;
Brunet, Jean-Philippe ;
Ahmann, Gregory J. ;
Adli, Mazhar ;
Anderson, Kenneth C. ;
Ardlie, Kristin G. ;
Auclair, Daniel ;
Baker, Angela ;
Bergsagel, P. Leif ;
Bernstein, Bradley E. ;
Drier, Yotam ;
Fonseca, Rafael ;
Gabriel, Stacey B. ;
Hofmeister, Craig C. ;
Jagannath, Sundar ;
Jakubowiak, Andrzej J. ;
Krishnan, Amrita ;
Levy, Joan ;
Liefeld, Ted ;
Lonial, Sagar ;
Mahan, Scott ;
Mfuko, Bunmi ;
Monti, Stefano ;
Perkins, Louise M. ;
Onofrio, Robb ;
Pugh, Trevor J. ;
Rajkumar, S. Vincent ;
Ramos, Alex H. ;
Siegel, David S. ;
Sivachenko, Andrey ;
Stewart, A. Keith ;
Trudel, Suzanne ;
Vij, Ravi ;
Voet, Douglas ;
Winckler, Wendy ;
Zimmerman, Todd ;
Carpten, John ;
Trent, Jeff ;
Hahn, William C. ;
Garraway, Levi A. ;
Meyerson, Matthew ;
Lander, Eric S. ;
Getz, Gad ;
Golub, Todd R. .
NATURE, 2011, 471 (7339) :467-472